Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeks

Article Abstract:

Giving HIV patients ritonavir and nelfinavir together may be beneficial, according to a study of 20 HIV patients. Both drugs are protease inhibitors and ritonavir slows the metabolism of other drugs, making them last longer in the body.

Author: Gallant, Joel E., Flexner, Charles, Raines, Charles P., Sun, Eugene, Heath-Chiozzi, Margo, Lewis, Ronald H., Fields, Cathy, Deetz, Carl, Apuzzo, Linda, Eshleman, Susan H., Jackson, J. Brooks
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2000
Evaluation, Ritonavir

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Characterization of Nevirapine resistance mutations in women with subtype A Vs. D HIV-1 6-8 weeks after single-dose Nevirapine (HIVNET 012)

Article Abstract:

The study reveals the comparison between number and type of nevirapine (NVP) detected in Uganda women with subtype A vs. D HIV-1 infection after single-dose NVP prophylaxis. Result of the study confirms a higher rate of NVPR in women with subtype D than A.

Author: Eshleman, Susan H., Jackson, J. Brooks, Guay, Laura A., Mwatha, Anthony,;, Brown, Elizabeth R., Cunninggham, Shawn P., Musoke, Philippa, MBChB, Mmiro, Francis,
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2004
HIV (Viruses), HIV, HIV patients, Women's health, Properties

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012

Article Abstract:

A study demonstrates that HIV-1 subtype can influence emergence and fading of specific nevirapine resistance (NVPR) mutations after single-dose NVP exposure. Rapid fading of variants with Y181C mutation was observed for women with subtype A, but not for women with subtype D.

Author: Mwatha, Anthony, Eshleman, Susan H., Jackson, J. Brooks, Guay, Laura A., Brown, Elizabeth R., Jing Wang, Musoke, Philippa, Mmiro, Francis
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2005
Prevention, HIV infection in children, Pediatric HIV infections, Dosage and administration

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: HIV infection, Drug therapy, HIV infections, Research, Nevirapine
Similar abstracts:
  • Abstracts: Presence of mutation conferring resistance to lamivudine in plasma and cerebrospinal fluid of HIV-1 infected patients
  • Abstracts: Comparison of T-cell subsets' reconstitution after 12 months of highly active antiretroviral therapy initiated durign early versus advanced states fo HIV disease
  • Abstracts: Mode of delivery and postpartum morbidity among HIV-infected women: the Women and Infants Transmission Study. Multicenter review of protease inhibitors in 89 pregnancies
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.